Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Aprepitant
- Therapeutic area
- Gastrointestinal & hepatology
- Drug class
- Antiemetics
- ATC
- A04
- Strength
- 125 mg
- Dosage form
- Capsule
- Pack
- 2's
- Registration no.
- 104467
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Vomion 125 mg capsule
Vomion 125 mg capsule contains Aprepitant 125 mg. It is registered with DRAP by HIGH-Q Pharmaceuticals (registration no. 104467). Its official price is PKR 5,212.96 for a pack of 2's, about PKR 2,606.48 per capsule. This price has applied since 18 August 2025. Vomion is also available as 40 mg capsule and 80 mg capsule. 14 other brands of Aprepitant 125 mg (capsule) are registered in Pakistan. Compare all brands and prices →
Other strengths of Vomion
Other brands of Aprepitant 125 mg
Official price over time
No change in the official DRAP price is recorded for this pack (2's). Current price PKR 5,212.96, effective 18 Aug 2025.
Cite this price history
MedInfoBase. Vomion 125 mg, 2's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/vomion-125-mg-104467-2s-high-q-pharmaceuticals/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 5,212.96 | 2025-08-18 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 104467Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
